Cardiogenic Shock in Takotsubo Syndrome: Incidence, Predictors, and Outcomes Results from the RETAKO registery

Cardiogenic shock (CS) is not a rare complication in patients with Takotsubo syndrome (TTS). Moreover, it is associated with an increased risk of adverse outcomes in the short- and long-term follow-up, according to a new study published in the Journal of the American College of Cardiology. Continue reading →

Drug-Eluting Stents Fare Better Than Bare-Metal Stents in Patients With High Bleeding Risk Efficacy and Safety of Drug-Eluting Stents Optimized for Biocompatibility vs Bare-Metal Stents With a Single Month of Dual Antiplatelet Therapy: A Meta-analysis

A meta-analysis conducted by Shah and his colleagues published in JAMA cardiology demonstrated that in patients with high bleeding risk, coronary interventions with drug-eluting stents (DES) optimized for biocompatibility were preferable over those with bare-metal stents (BMS) in terms of both safety and efficacy, in patients with only 1 month of Dual Antiplatelet therapy (DAPT). Continue reading →